BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6337761)

  • 1. Indenolol in hypertension.
    Sega R; Mailland F; Damiani E; Groothold G; Libretti A
    Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
    Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Palazzo F; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1819-21. PubMed ID: 3534631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of indenolol at rest and after a submaximal workload in essential hypertension.
    Aiello C; Groothold G; Gualtieri S; Irace L; Marini IL; Perna B; Romano A
    Eur J Clin Pharmacol; 1985; 28(5):501-5. PubMed ID: 3899670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
    Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
    J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
    Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
    Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
    Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
    J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indenolol kinetics versus pharmacodynamics in hypertension.
    Mailland F; Groothold G; Poli A; Pantarotto C
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):567-74. PubMed ID: 2877127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
    Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
    J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
    Taddei S; Pedrinelli R; Salvetti A
    Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
    Zuccari G; Falcone A; Turba C
    Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response studies of indenolol, a beta adrenoceptor blocker.
    Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose response studies of bevantolol in hypertensive patients.
    Okawa KK
    Angiology; 1986 Mar; 37(3 Pt 2):233-8. PubMed ID: 2871783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
    Poggesi L; Masotti G; Boddi M; Neri Serneri GG
    Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized echocardiographic study of left ventricular function and cardiodynamic investigation with a new antihypertensive agent (indenolol).
    Venco A; Groothold G; Grandi A; Barzizza F; Corradi L; Negri F; Finardi G
    Clin Ther; 1985; 7(3):347-56. PubMed ID: 3995529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of increasing doses of urapidil in patients with hypertension.
    Culbertson VL; Bryant PJ; Cady WJ; Rubison RM; Piepho RW; Nies AS; Byyny RL
    Clin Pharmacol Ther; 1986 Jun; 39(6):690-6. PubMed ID: 3519043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of once and twice daily atenolol in hypertension.
    Castleden CM; Dathan JR; George CF
    Postgrad Med J; 1977 Nov; 53(625):679-82. PubMed ID: 339214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.